Global Inflammatory POCT Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Inflammatory POCT Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Based on Immunochromatography
- 1.3.3 Based on Chemiluminescence
- 1.3.4 Based on Microfluidic Chip
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Inflammatory POCT Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 C-Reactive Protein (CRP) Test
- 1.4.3 Procalcitonin (PCT) Test
- 1.4.4 Interleukin 6 (IL-6) Test
- 1.4.5 Serum amyloid A (SAA) Test
- 1.4.6 Others
- 1.5 Global Inflammatory POCT Market Size & Forecast
- 1.5.1 Global Inflammatory POCT Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Inflammatory POCT Sales Quantity (2021-2032)
- 1.5.3 Global Inflammatory POCT Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Roche
- 2.1.1 Roche Details
- 2.1.2 Roche Major Business
- 2.1.3 Roche Inflammatory POCT Product and Services
- 2.1.4 Roche Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Roche Recent Developments/Updates
- 2.2 Abbott
- 2.2.1 Abbott Details
- 2.2.2 Abbott Major Business
- 2.2.3 Abbott Inflammatory POCT Product and Services
- 2.2.4 Abbott Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Abbott Recent Developments/Updates
- 2.3 Siemens Healthineers
- 2.3.1 Siemens Healthineers Details
- 2.3.2 Siemens Healthineers Major Business
- 2.3.3 Siemens Healthineers Inflammatory POCT Product and Services
- 2.3.4 Siemens Healthineers Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Siemens Healthineers Recent Developments/Updates
- 2.4 BioMerieux
- 2.4.1 BioMerieux Details
- 2.4.2 BioMerieux Major Business
- 2.4.3 BioMerieux Inflammatory POCT Product and Services
- 2.4.4 BioMerieux Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 BioMerieux Recent Developments/Updates
- 2.5 Bio-Rad Laboratories
- 2.5.1 Bio-Rad Laboratories Details
- 2.5.2 Bio-Rad Laboratories Major Business
- 2.5.3 Bio-Rad Laboratories Inflammatory POCT Product and Services
- 2.5.4 Bio-Rad Laboratories Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Bio-Rad Laboratories Recent Developments/Updates
- 2.6 Assure Tech
- 2.6.1 Assure Tech Details
- 2.6.2 Assure Tech Major Business
- 2.6.3 Assure Tech Inflammatory POCT Product and Services
- 2.6.4 Assure Tech Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Assure Tech Recent Developments/Updates
- 2.7 Guangzhou Wondfo Biotech Co.,Ltd.
- 2.7.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
- 2.7.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
- 2.7.3 Guangzhou Wondfo Biotech Co.,Ltd. Inflammatory POCT Product and Services
- 2.7.4 Guangzhou Wondfo Biotech Co.,Ltd. Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
- 2.8 Wuhan Easy Diagnosis
- 2.8.1 Wuhan Easy Diagnosis Details
- 2.8.2 Wuhan Easy Diagnosis Major Business
- 2.8.3 Wuhan Easy Diagnosis Inflammatory POCT Product and Services
- 2.8.4 Wuhan Easy Diagnosis Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Wuhan Easy Diagnosis Recent Developments/Updates
- 2.9 Getein Biotech
- 2.9.1 Getein Biotech Details
- 2.9.2 Getein Biotech Major Business
- 2.9.3 Getein Biotech Inflammatory POCT Product and Services
- 2.9.4 Getein Biotech Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Getein Biotech Recent Developments/Updates
- 2.10 Beijing Hotgen Biotech Co.,ltd.
- 2.10.1 Beijing Hotgen Biotech Co.,ltd. Details
- 2.10.2 Beijing Hotgen Biotech Co.,ltd. Major Business
- 2.10.3 Beijing Hotgen Biotech Co.,ltd. Inflammatory POCT Product and Services
- 2.10.4 Beijing Hotgen Biotech Co.,ltd. Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
- 2.11 Shanghai Upper Bio-Tech Pharma Co.,Ltd.
- 2.11.1 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Details
- 2.11.2 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Major Business
- 2.11.3 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Inflammatory POCT Product and Services
- 2.11.4 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments/Updates
- 2.12 Qingdao Hightop Biotech Co., Ltd.
- 2.12.1 Qingdao Hightop Biotech Co., Ltd. Details
- 2.12.2 Qingdao Hightop Biotech Co., Ltd. Major Business
- 2.12.3 Qingdao Hightop Biotech Co., Ltd. Inflammatory POCT Product and Services
- 2.12.4 Qingdao Hightop Biotech Co., Ltd. Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Qingdao Hightop Biotech Co., Ltd. Recent Developments/Updates
- 2.13 Goldsite Diagnostics Inc.
- 2.13.1 Goldsite Diagnostics Inc. Details
- 2.13.2 Goldsite Diagnostics Inc. Major Business
- 2.13.3 Goldsite Diagnostics Inc. Inflammatory POCT Product and Services
- 2.13.4 Goldsite Diagnostics Inc. Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Goldsite Diagnostics Inc. Recent Developments/Updates
- 2.14 Genrui Biotech Inc
- 2.14.1 Genrui Biotech Inc Details
- 2.14.2 Genrui Biotech Inc Major Business
- 2.14.3 Genrui Biotech Inc Inflammatory POCT Product and Services
- 2.14.4 Genrui Biotech Inc Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Genrui Biotech Inc Recent Developments/Updates
- 2.15 Hipro Biotechnology CO.,LTD
- 2.15.1 Hipro Biotechnology CO.,LTD Details
- 2.15.2 Hipro Biotechnology CO.,LTD Major Business
- 2.15.3 Hipro Biotechnology CO.,LTD Inflammatory POCT Product and Services
- 2.15.4 Hipro Biotechnology CO.,LTD Inflammatory POCT Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Hipro Biotechnology CO.,LTD Recent Developments/Updates
3 Competitive Environment: Inflammatory POCT by Manufacturer
- 3.1 Global Inflammatory POCT Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Inflammatory POCT Revenue by Manufacturer (2021-2026)
- 3.3 Global Inflammatory POCT Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Inflammatory POCT by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Inflammatory POCT Manufacturer Market Share in 2025
- 3.4.3 Top 6 Inflammatory POCT Manufacturer Market Share in 2025
- 3.5 Inflammatory POCT Market: Overall Company Footprint Analysis
- 3.5.1 Inflammatory POCT Market: Region Footprint
- 3.5.2 Inflammatory POCT Market: Company Product Type Footprint
- 3.5.3 Inflammatory POCT Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Inflammatory POCT Market Size by Region
- 4.1.1 Global Inflammatory POCT Sales Quantity by Region (2021-2032)
- 4.1.2 Global Inflammatory POCT Consumption Value by Region (2021-2032)
- 4.1.3 Global Inflammatory POCT Average Price by Region (2021-2032)
- 4.2 North America Inflammatory POCT Consumption Value (2021-2032)
- 4.3 Europe Inflammatory POCT Consumption Value (2021-2032)
- 4.4 Asia-Pacific Inflammatory POCT Consumption Value (2021-2032)
- 4.5 South America Inflammatory POCT Consumption Value (2021-2032)
- 4.6 Middle East & Africa Inflammatory POCT Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Inflammatory POCT Sales Quantity by Type (2021-2032)
- 5.2 Global Inflammatory POCT Consumption Value by Type (2021-2032)
- 5.3 Global Inflammatory POCT Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Inflammatory POCT Sales Quantity by Application (2021-2032)
- 6.2 Global Inflammatory POCT Consumption Value by Application (2021-2032)
- 6.3 Global Inflammatory POCT Average Price by Application (2021-2032)
7 North America
- 7.1 North America Inflammatory POCT Sales Quantity by Type (2021-2032)
- 7.2 North America Inflammatory POCT Sales Quantity by Application (2021-2032)
- 7.3 North America Inflammatory POCT Market Size by Country
- 7.3.1 North America Inflammatory POCT Sales Quantity by Country (2021-2032)
- 7.3.2 North America Inflammatory POCT Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Inflammatory POCT Sales Quantity by Type (2021-2032)
- 8.2 Europe Inflammatory POCT Sales Quantity by Application (2021-2032)
- 8.3 Europe Inflammatory POCT Market Size by Country
- 8.3.1 Europe Inflammatory POCT Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Inflammatory POCT Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Inflammatory POCT Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Inflammatory POCT Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Inflammatory POCT Market Size by Region
- 9.3.1 Asia-Pacific Inflammatory POCT Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Inflammatory POCT Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Inflammatory POCT Sales Quantity by Type (2021-2032)
- 10.2 South America Inflammatory POCT Sales Quantity by Application (2021-2032)
- 10.3 South America Inflammatory POCT Market Size by Country
- 10.3.1 South America Inflammatory POCT Sales Quantity by Country (2021-2032)
- 10.3.2 South America Inflammatory POCT Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Inflammatory POCT Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Inflammatory POCT Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Inflammatory POCT Market Size by Country
- 11.3.1 Middle East & Africa Inflammatory POCT Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Inflammatory POCT Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Inflammatory POCT Market Drivers
- 12.2 Inflammatory POCT Market Restraints
- 12.3 Inflammatory POCT Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Inflammatory POCT and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Inflammatory POCT
- 13.3 Inflammatory POCT Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Inflammatory POCT Typical Distributors
- 14.3 Inflammatory POCT Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Inflammatory POCT market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Inflammatory POCT market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Inflammatory POCT market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Inflammatory POCT market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Inflammatory POCT market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Inflammatory POCT market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Inflammatory POCT
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Inflammatory POCT market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Abbott, Siemens Healthineers, BioMerieux, Bio-Rad Laboratories, Assure Tech, Guangzhou Wondfo Biotech Co.,Ltd., Wuhan Easy Diagnosis, Getein Biotech, Beijing Hotgen Biotech Co.,ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Inflammatory POCT market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Based on Immunochromatography
Based on Chemiluminescence
Based on Microfluidic Chip
Market segment by Application
C-Reactive Protein (CRP) Test
Procalcitonin (PCT) Test
Interleukin 6 (IL-6) Test
Serum amyloid A (SAA) Test
Others
Major players covered
Roche
Abbott
Siemens Healthineers
BioMerieux
Bio-Rad Laboratories
Assure Tech
Guangzhou Wondfo Biotech Co.,Ltd.
Wuhan Easy Diagnosis
Getein Biotech
Beijing Hotgen Biotech Co.,ltd.
Shanghai Upper Bio-Tech Pharma Co.,Ltd.
Qingdao Hightop Biotech Co., Ltd.
Goldsite Diagnostics Inc.
Genrui Biotech Inc
Hipro Biotechnology CO.,LTD
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Inflammatory POCT product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Inflammatory POCT, with price, sales quantity, revenue, and global market share of Inflammatory POCT from 2021 to 2026.
Chapter 3, the Inflammatory POCT competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inflammatory POCT breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Inflammatory POCT market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Inflammatory POCT.
Chapter 14 and 15, to describe Inflammatory POCT sales channel, distributors, customers, research findings and conclusion.